Genoway Financials
| ALGEN Stock | EUR 3.70 0.08 2.12% |
Genoway |
Understanding current and past Genoway Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genoway's financial statements are interrelated, with each one affecting the others. For example, an increase in Genoway's assets may result in an increase in income on the income statement.
Genoway Stock Summary
Genoway competes with Eurobio Scientific, Biosynex, and Biophytis. genOway S.A., a biotechnology company, engages in the development and sale of custom genetically-modified mouse, rat, and cellular models worldwide. The company was founded in 1999 and is based in Lyon, France. GENOWAY operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 105 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0004053510 |
| Business Address | Technopark 2, Lyon, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.genoway.com |
| Phone | 33 4 37 65 41 00 |
| Currency | EUR - Euro |
You should never invest in Genoway without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genoway Stock, because this is throwing your money away. Analyzing the key information contained in Genoway's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genoway Key Financial Ratios
Genoway's financial ratios allow both analysts and investors to convert raw data from Genoway's financial statements into concise, actionable information that can be used to evaluate the performance of Genoway over time and compare it to other companies across industries.| Return On Equity | 0.038 | |||
| Return On Asset | 0.0019 | |||
| Target Price | 2.78 | |||
| Number Of Employees | 128 | |||
| Beta | 0.56 |
Genoway Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genoway's current stock value. Our valuation model uses many indicators to compare Genoway value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genoway competition to find correlations between indicators driving Genoway's intrinsic value. More Info.Genoway is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.05 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genoway is roughly 20.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genoway's earnings, one of the primary drivers of an investment's value.Genoway Systematic Risk
Genoway's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genoway volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Genoway correlated with the market. If Beta is less than 0 Genoway generally moves in the opposite direction as compared to the market. If Genoway Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genoway is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genoway is generally in the same direction as the market. If Beta > 1 Genoway moves generally in the same direction as, but more than the movement of the benchmark.
Genoway November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genoway help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genoway. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genoway based on widely used predictive technical indicators. In general, we focus on analyzing Genoway Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genoway's daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 8.49 | |||
| Value At Risk | (3.06) | |||
| Potential Upside | 3.16 |
Additional Tools for Genoway Stock Analysis
When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.